• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Drug Resistance

An artists depiction of E coli one of the many bacteria that is becoming resistant to first-line antibiotics The bacteria
Research

Synthetic antibiotic shows 'potent' efficacy against superbugs

From AI to a once-rejected drug, the arsenal of potential weapons against antibiotic resistance is growing at last. Now, a new player joins the fray.
Helen Floersh Aug 14, 2023 5:00am
Novartis building

Racing resistance, Novartis plans pivotal malaria drug trial

Nov 23, 2022 7:20am
RNA strand

Multidrug-resistant pathogen targets RNA of competitor bacteria

Sep 7, 2022 5:11pm
Antibiotic-resistant bacteria

Boehringer rounds up allies to build €40M anti-superbug startup

Jul 6, 2022 6:01am
Cytomegalovirus CMV herpes herpesvirus virus

New antiviral class could halt treatment-resistant viruses

May 16, 2022 3:10pm
Antibiotics

Lack of policy, investment stifling antibiotics pipeline

Apr 12, 2022 9:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings